201 related articles for article (PubMed ID: 23409394)
21. Predictors of CD4 count over time among HIV patients initiated ART in Felege Hiwot Referral Hospital, northwest Ethiopia: multilevel analysis.
Gezie LD
BMC Res Notes; 2016 Jul; 9():377. PubMed ID: 27475982
[TBL] [Abstract][Full Text] [Related]
22. Antiretroviral drug therapy in HIV-infected Jamaican children.
Evans-Gilbert T; Pierre R; Steel-Duncan JC; Rodriguez B; Whorms S; Hambleton IR; Figueroa JP; Christie CD
West Indian Med J; 2004 Oct; 53(5):322-6. PubMed ID: 15675498
[TBL] [Abstract][Full Text] [Related]
23. Long-term response to combination antiretroviral therapy in HIV-infected children in the Netherlands registered from 1996 to 2012.
Cohen S; Smit C; van Rossum AM; Fraaij PL; Wolfs TF; Geelen SP; Schölvinck EH; Warris A; Scherpbier HJ; Pajkrt D;
AIDS; 2013 Oct; 27(16):2567-75. PubMed ID: 23842124
[TBL] [Abstract][Full Text] [Related]
24. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
[TBL] [Abstract][Full Text] [Related]
25. Predictors of early mortality in a cohort of HIV-infected children receiving high active antiretroviral treatment in public hospitals in Ethiopia.
Ebissa G; Deyessa N; Biadgilign S
AIDS Care; 2015; 27(6):723-30. PubMed ID: 25599414
[TBL] [Abstract][Full Text] [Related]
26. Effect of antiretroviral therapy in human immunodeficiency virus-infected children.
Chearskul P; Chokephaibulkit K; Chearskul S; Phongsamart W; Plipat N; Lapphra K; Vanprapar N
J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S221-31. PubMed ID: 16856444
[TBL] [Abstract][Full Text] [Related]
27. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
Moore RD; Keruly JC
Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
[TBL] [Abstract][Full Text] [Related]
28. Predictors of antiretroviral treatment-associated tuberculosis in Ethiopia: a nested case-control study.
Mesfin N; Deribew A; Yami A; Solomon T; Van Geertruyden JP; Colebunders R
Int J STD AIDS; 2012 Feb; 23(2):94-8. PubMed ID: 22422682
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of highly active antiretroviral therapy in HIV-1 infected children in Kenya.
Song R; Jelagat J; Dzombo D; Mwalimu M; Mandaliya K; Shikely K; Essajee S
Pediatrics; 2007 Oct; 120(4):e856-61. PubMed ID: 17846147
[TBL] [Abstract][Full Text] [Related]
30. The prognostic value of baseline CD4(+) cell count beyond 6 months of antiretroviral therapy in HIV-positive patients in a resource-limited setting.
Mills EJ; Bakanda C; Birungi J; Yaya S; Ford N;
AIDS; 2012 Jul; 26(11):1425-9. PubMed ID: 22526520
[TBL] [Abstract][Full Text] [Related]
31. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
[TBL] [Abstract][Full Text] [Related]
32. Antiretroviral Service to HIV patients of low CD4 count in Seti Zonal Hospital.
Paudel BN; Chaudhary SR; Sharma S; Dhungana GP; Paudel P
JNMA J Nepal Med Assoc; 2009; 48(173):24-7. PubMed ID: 19529054
[TBL] [Abstract][Full Text] [Related]
33. Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited.
Orrell C; Harling G; Lawn SD; Kaplan R; McNally M; Bekker LG; Wood R
Antivir Ther; 2007; 12(1):83-8. PubMed ID: 17503751
[TBL] [Abstract][Full Text] [Related]
34. The cost effectiveness of antiretroviral treatment strategies in resource-limited settings.
Bishai D; Colchero A; Durack DT
AIDS; 2007 Jun; 21(10):1333-40. PubMed ID: 17545710
[TBL] [Abstract][Full Text] [Related]
35. Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settings.
Schneider K; Puthanakit T; Kerr S; Law MG; Cooper DA; Donovan B; Phanuphak N; Sirisanthana V; Ananworanich J; Ohata J; Wilson DP
AIDS; 2011 Jun; 25(9):1143-51. PubMed ID: 21505319
[TBL] [Abstract][Full Text] [Related]
36. Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children.
Resino S; Larrú B; Maria Bellón J; Resino R; de José MI; Navarro M; Léon JA; Ramos JT; Mellado MJ; Muñoz-Fernández MA
BMC Infect Dis; 2006 Jul; 6():107. PubMed ID: 16834769
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcome of children receiving antiretroviral treatment in rural South Africa: substantial virologic failure on first-line treatment.
Barth RE; Tempelman HA; Smelt E; Wensing AM; Hoepelman AI; Geelen SP
Pediatr Infect Dis J; 2011 Jan; 30(1):52-6. PubMed ID: 20631647
[TBL] [Abstract][Full Text] [Related]
38. Reliability of absolute lymphocyte count as a marker to assess the need to initiate antiretroviral therapy in HIV-infected children.
Shah I; Parikh S
J Postgrad Med; 2012; 58(3):176-9. PubMed ID: 23023348
[TBL] [Abstract][Full Text] [Related]
39. Sex Differences in Antiretroviral Therapy Initiation in Pediatric HIV Infection.
Mori M; Adland E; Paioni P; Swordy A; Mori L; Laker L; Muenchhoff M; Matthews PC; Tudor-Williams G; Lavandier N; van Zyl A; Hurst J; Walker BD; Ndung'u T; Prendergast A; Goulder P; Jooste P
PLoS One; 2015; 10(7):e0131591. PubMed ID: 26151555
[TBL] [Abstract][Full Text] [Related]
40. Feasibility and effectiveness of early initiation of combination antiretroviral therapy in HIV-infected infants in a government clinic of Kwazulu-Natal, South Africa.
Purchase SE; Van der Linden DJ; McKerrow NH
J Trop Pediatr; 2012 Apr; 58(2):114-9. PubMed ID: 21705764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
